Seeing Is Believing

Currently out of the existing stock ratings of Robbie Marcus, 164 are a BUY (58.99%), 93 are a HOLD (33.45%), 21 are a SELL (7.55%).
Analyst Robbie Marcus, currently employed at JPMORGAN, carries an average stock price target met ratio of 64.2% that have a potential upside of 19.48% achieved within 143 days.
Robbie Marcus’s has documented 530 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EW, Edwards Lifesciences Corp at 18-Dec-2025.
Analyst best performing recommendations are on TMCI (TREACE MEDICAL CONCEPTS).
The best stock recommendation documented was for INSP (INSPIRE MEDICAL SYSTEMS) at 11/4/2025. The price target of $82 was fulfilled within 1 day with a profit of $8.29 (11.25%) receiving and performance score of 112.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$0.74
$0.52 (236.36%)
$1
2 years 5 months 23 days ago
(08-Aug-2023)
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
$1.5
$1.28 (581.82%)
3 years 5 months 15 days ago
(16-Aug-2022)
1/2 (50%)
$0.05 (3.45%)
2
Buy
$1.5
$1.28 (581.82%)
3 years 7 months 7 days ago
(24-Jun-2022)
1/5 (20%)
$0.96 (177.78%)
27
Sell
$19
4 years 2 months 20 days ago
(12-Nov-2021)
0/2 (0%)
$3.71 (16.84%)
Hold
$23
$21.36 (1302.44%)
$30
4 years 10 months 12 days ago
(19-Mar-2021)
0/3 (0%)
$4.37 (22.18%)
Which stock is Robbie Marcus is most bullish on?
Which stock is Robbie Marcus is most reserved on?
What Year was the first public recommendation made by Robbie Marcus?